Ostrominski JW, Vaduganathan M, Selvaraj S, Claggett BL, Miao ZM, Desai AS, Jhund PS, Kosiborod MN, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Hernandez AF, Shah SJ, Petersson M, Maria Langkilde A, McMurray JJV, Solomon SD
Read more on the growing tension between affordability and risk: #OncologyPractice #SpecialtyPharmacy #HealthcarePolicy #PharmacyBenefits #OncologyLeadership #ValueBasedCare To view or add a comment, sign in Eli Lillys ultimatum that it will cut off 340B drug discounts to hospitals that refuse to share claims data sets up another legal battle between drugmakers and providers
That distinctive smell comes from hydrogen sulfide, a gas produced when bacteria in your gut break down sulfur-containing compounds in food
2020;105(4):e154960
Under the treatment-regimen estimand, reflecting real-world adherence conditions, the figures were 20.2% versus 23.6%